Alkaloids as Potential Anti-HIV Agents

Curr HIV Res. 2023;21(4):240-247. doi: 10.2174/1570162X21666230608114130.

Abstract

Background: Alkaloids are nitrogen-containing compounds that are naturally occurring and have a variety of biological activities, including antimicrobial properties. In this study, the authors used a molecular docking approach to evaluate the anti-HIV potential of 64 alkaloids.

Methods: The authors used the Molegro Virtual Docker software to dock the alkaloids into the active sites of three HIV enzymes: protease, integrase, and non-nucleoside reverse transcriptase (NNRT). The docking scores were used to assess the potential of the alkaloids to inhibit the enzymes.

Results: The results showed the alkaloids to have good potential to inhibit the enzymes. Tubocurarine and reserpine were found to be the most potent alkaloids, with docking scores of -123.776 and - 114.956, respectively.

Conclusion: The authors concluded that tubocurarine and reserpine could be further promoted as potential lead molecules for the development of new anti-HIV drugs.

Keywords: Anti-HIV; Molegro Virtual Docker.; integrase inhibitors; molecular docking; non-nucleoside reverse transcriptase inhibitors; protease inhibitors.

MeSH terms

  • Alkaloids* / pharmacology
  • Alkaloids* / therapeutic use
  • Anti-HIV Agents* / chemistry
  • Anti-HIV Agents* / pharmacology
  • Anti-HIV Agents* / therapeutic use
  • HIV Infections* / drug therapy
  • HIV Reverse Transcriptase / chemistry
  • Humans
  • Molecular Docking Simulation
  • Reserpine / pharmacology
  • Reverse Transcriptase Inhibitors / pharmacology
  • Tubocurarine

Substances

  • Anti-HIV Agents
  • Tubocurarine
  • Reserpine
  • Alkaloids
  • HIV Reverse Transcriptase
  • Reverse Transcriptase Inhibitors